| CDD for Biologics Summit Boston 2017 | |
|
United States - MA - Boston |
|
| Hosted by: | Hanson Wade |
| Venue: | Revere Hotel Boston Common, 200 Stuart Street, 02116 |
| Dates: | Dec 05, 2017 through Dec 07, 2017 |
|
Description |
|
| Biologic-based therapeutics have continued to become more complex both by modality and delivery. Much like the small molecule arena, computational tools are being sought to streamline drug design, development and manufacture. The 2nd Annual Computational Drug Development (CDD) for Biologics Summit is dedicated to exploring the application of in-silico tools within the development paradigm for biologics. Designed with input from thought leaders at organizations such as Genentech, Bristol-Myers Squibb, AbbVie, EMD Serono and Novartis, identify how to streamline your early drug discovery pipeline, enhance developability and improve the success rate of lead biologic candidates. * Please note: We also offer a start-up rate for small biotech organisations, as well as academic discounts. For more information and to check eligibility criteria, please visit the website. * |
|
| Additional Information | |
| Event URL: | https://go.evvnt.com/158061-0 |
| ISCB Member Discount: | None |
| Contact Person: | Customer Services ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
